PTPRR and neoplasm: Moreover, PTPR-injection led to downregulation of PD-L1 in tumors and changes in the immune microenvironment of tumors, especially the upregulation of total and activated CD8+ cytotoxic T cells levels in tumor-infiltrating lymphocytes (Fig. 7f–i and Supplementary Fig. 13a–f).